Highlights
KLSE: HARTA (5168)       HARTALEGA HOLDINGS BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
5.89   0.00 (0.00%)  0.00 - 0.00  0
Analyze this stock with MQ Trader system

Financials


Market Cap: 19,905 Million

Market Cap 19,905 Million
NOSH 3,379 Million

Latest Audited Result:  31-Mar-2017

Latest Audited Result: 31-Mar-2017
Announcement Date 31-Jul-2017
Next Audited Result: 31-Mar-2018
Est. Ann. Date: 31-Jul-2018
Est. Ann. Due Date: 27-Sep-2018

Latest Quarter:  31-Dec-2019 [#3]

Latest Quarter: 31-Dec-2019 [#3]
Announcement Date 11-Feb-2020
Next Quarter: 31-Mar-2020
Est. Ann. Date: 07-May-2020
Est. Ann. Due Date: 30-May-2020
QoQ | YoY   16.76%  |    1.27%

Annual (Unaudited) ( EPS: 13.50, P/E: 43.63 )

Revenue | NP to SH 2,827,879  |  456,204
RPS | P/RPS 83.68 Cent  |  7.04
EPS | P/E | EY 13.50 Cent  |  43.63  |  2.29%
DPS | DY | Payout % 8.37 Cent  |  1.42%  |  61.97%
NAPS | P/NAPS 0.66  |  8.93
YoY   3.83%
NP Margin | ROE 16.13%  |  20.47%
F.Y. | Ann. Date 31-Mar-2019  |  07-May-2019

T4Q Result ( EPS: 12.15, P/E: 48.48 )

Revenue | NP to SH 2,829,964  |  410,563
RPS | P/RPS 83.74 Cent  |  7.03
EPS | P/E | EY 12.15 Cent  |  48.48  |  2.06%
DPS | DY | Payout % 7.33 Cent  |  1.24%  |  60.36%
NAPS | P/NAPS 0.73  |  8.11
QoQ | YoY   0.37%  |    -14.73%
NP Margin | ROE 14.54%  |  16.72%
F.Y. | Ann. Date 31-Dec-2019  |  11-Feb-2020

Annualized Result ( EPS: 12.59, P/E: 46.77 )

Revenue | NP to SH 2,861,433  |  425,604
RPS | P/RPS 84.67 Cent  |  6.96
EPS | P/E | EY 12.59 Cent  |  46.77  |  2.14%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   7.51%  |    -12.51%
NP Margin | ROE 14.92%  |  17.33%
F.Y. | Ann. Date 31-Dec-2019  |  11-Feb-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Mar-2020 11-Feb-2020 31-Dec-2019 3 796,550 159,697 121,661 121,273 60,557 2,455,939 49.93% 15.27% 4.94% 3,364,301 23.68 23.57 3.60 3.59 1.80 1.79 0.7300 0.73   16.76%   1.27% 31-Dec-2019 5.48 23.15 152.02 7.51 0.66% 0.33% 11-Feb-2020 6.00 25.34 166.45 8.22 0.60% 0.30%
31-Mar-2020 05-Nov-2019 30-Sep-2019 2 709,424 137,327 104,206 103,867 60,421 2,349,722 58.17% 14.69% 4.42% 3,356,746 21.13 20.99 3.09 3.07 1.80 1.79 0.7000 0.70   10.42%   -13.60% 30-Sep-2019 5.25 24.84 169.67 7.50 0.59% 0.34% 05-Nov-2019 5.47 25.88 176.78 7.81 0.57% 0.33%
31-Mar-2020 06-Aug-2019 30-Jun-2019 1 640,101 121,654 94,254 94,063 63,651 2,311,569 67.67% 14.72% 4.07% 3,350,101 19.11 18.94 2.81 2.78 1.90 1.88 0.6900 0.68   2.96%   -24.67% 28-Jun-2019 5.24 27.42 186.63 7.59 0.54% 0.36% 06-Aug-2019 5.05 26.43 179.86 7.32 0.56% 0.38%
31-Mar-2019 07-May-2019 31-Mar-2019 4 683,889 113,680 91,414 91,360 63,195 2,228,470 69.17% 13.37% 4.10% 3,326,075 20.56 20.24 2.75 2.70 1.90 1.87 0.6700 0.66   -23.71%   -21.68% 29-Mar-2019 4.63 22.52 168.56 6.91 0.59% 0.41% 07-May-2019 5.05 24.56 183.85 7.54 0.54% 0.38%
31-Mar-2019 12-Feb-2019 31-Dec-2018 3 723,393 150,001 119,335 119,755 73,136 2,194,080 61.07% 16.50% 5.46% 3,324,364 21.76 21.41 3.60 3.54 2.20 2.16 0.6600 0.65   -0.38%   5.96% 31-Dec-2018 6.14 28.22 170.44 9.30 0.59% 0.36% 12-Feb-2019 5.45 25.05 151.29 8.26 0.66% 0.40%
31-Mar-2019 08-Nov-2018 30-Sep-2018 2 714,244 142,352 120,381 120,216 73,070 2,125,679 60.78% 16.85% 5.66% 3,321,375 21.50 21.13 3.62 3.56 2.20 2.16 0.6400 0.63   -3.73%   6.07% 28-Sep-2018 6.62 30.78 182.90 10.34 0.55% 0.33% 08-Nov-2018 6.31 29.34 174.34 9.86 0.57% 0.35%
31-Mar-2019 07-Aug-2018 30-Jun-2018 1 706,353 145,833 125,088 124,873 72,948 2,055,827 58.42% 17.71% 6.07% 3,315,851 21.30 20.90 3.77 3.70 2.20 2.16 0.6200 0.61   7.05%   29.56% 29-Jun-2018 5.99 28.12 159.06 9.66 0.63% 0.37% 07-Aug-2018 6.17 28.96 163.84 9.95 0.61% 0.36%
31-Mar-2018 15-May-2018 31-Mar-2018 4 616,841 134,972 116,899 116,646 66,124 1,983,748 56.69% 18.95% 5.88% 3,306,247 18.66 18.25 3.53 3.45 2.00 1.96 0.6000 0.59   3.21%   30.44% 30-Mar-2018 6.05 32.43 171.48 10.08 0.58% 0.33% 15-May-2018 6.00 32.16 170.07 10.00 0.59% 0.33%
31-Mar-2018 06-Feb-2018 31-Dec-2017 3 603,139 138,857 113,123 113,023 65,991 1,930,255 58.39% 18.76% 5.86% 1,649,791 36.56 17.85 6.85 3.34 4.00 1.95 1.1700 0.57   -0.28%   70.66% 29-Dec-2017 10.68 29.21 155.90 9.13 0.64% 0.37% 06-Feb-2018 10.84 29.65 158.23 9.26 0.63% 0.37%
31-Mar-2018 28-Dec-2017 30-Sep-2017 2 584,617 137,245 113,738 113,340 57,505 1,849,699 50.74% 19.46% 6.13% 1,643,009 35.58 17.30 6.87 3.35 3.50 1.70 1.1258 0.55   17.59%   59.15% 29-Sep-2017 6.96 19.56 100.89 6.18 0.99% 0.50% 28-Dec-2017 10.82 30.41 156.85 9.61 0.64% 0.32%
31-Mar-2018 08-Aug-2017 30-Jun-2017 1 601,041 115,736 96,429 96,386 41,121 1,757,877 42.66% 16.04% 5.48% 1,644,875 36.54 17.78 5.86 2.85 2.50 1.22 1.0687 0.52   7.78%   71.58% 30-Jun-2017 7.38 20.20 125.94 6.91 0.79% 0.34% 08-Aug-2017 7.15 19.57 122.02 6.69 0.82% 0.35%
31-Mar-2017 09-May-2017 31-Mar-2017 4 526,997 118,505 89,439 89,427 32,817 1,680,079 36.70% 16.97% 5.32% 1,640,862 32.12 15.59 5.45 2.65 2.00 0.97 1.0239 0.50   35.03%   45.29% 31-Mar-2017 4.96 15.44 91.01 4.84 1.10% 0.40% 09-May-2017 5.39 16.78 98.90 5.26 1.01% 0.37%
31-Mar-2017 14-Feb-2017 31-Dec-2016 3 456,287 78,327 66,400 66,226 32,866 1,617,360 49.63% 14.55% 4.09% 1,643,324 27.77 13.50 4.03 1.96 2.00 0.97 0.9842 0.48   -7.01%   -9.01% 30-Dec-2016 4.83 17.40 119.85 4.91 0.83% 0.41% 14-Feb-2017 4.75 17.11 117.87 4.83 0.85% 0.42%
31-Mar-2017 08-Nov-2016 30-Sep-2016 2 436,975 83,759 71,177 71,215 32,817 1,575,262 46.08% 16.29% 4.52% 1,640,898 26.63 12.93 4.34 2.11 2.00 0.97 0.9600 0.47   26.77%   17.88% 30-Sep-2016 4.64 17.42 106.91 4.83 0.94% 0.43% 08-Nov-2016 4.78 17.95 110.14 4.98 0.91% 0.42%
31-Mar-2017 02-Aug-2016 30-Jun-2016 1 401,827 68,129 56,398 56,176 32,851 1,531,863 58.48% 14.04% 3.67% 1,642,573 24.46 11.89 3.42 1.66 2.00 0.97 0.9326 0.45   -8.73%   -10.38% 30-Jun-2016 4.33 17.70 126.61 4.64 0.79% 0.46% 02-Aug-2016 4.24 17.33 123.98 4.55 0.81% 0.47%
31-Mar-2016 03-May-2016 31-Mar-2016 4 400,454 70,712 61,531 61,550 32,828 1,502,218 53.34% 15.37% 4.10% 1,641,409 24.40 11.85 3.75 1.82 2.00 0.97 0.9152 0.44   -15.44%   11.97% 31-Mar-2016 4.85 19.88 129.34 5.30 0.77% 0.41% 03-May-2016 4.14 16.97 110.41 4.52 0.91% 0.48%
31-Mar-2016 16-Feb-2016 31-Dec-2015 3 398,023 91,173 72,886 72,786 32,786 146,506,417 45.05% 18.31% 0.05% 1,639,324 24.28 11.78 4.44 2.15 2.00 0.97 89.3700 43.35   20.48%   46.99% 31-Dec-2015 5.94 24.46 133.78 0.07 0.75% 0.34% 16-Feb-2016 4.98 20.51 112.16 0.06 0.89% 0.40%
31-Mar-2016 05-Nov-2015 30-Sep-2015 2 379,345 75,069 60,553 60,411 32,743 141,761,197 54.20% 15.96% 0.04% 1,637,154 23.17 11.22 3.69 1.79 2.00 0.97 86.5900 41.95   -3.62%   25.44% 30-Sep-2015 4.85 20.93 131.44 0.06 0.76% 0.41% 05-Nov-2015 5.22 22.53 141.46 0.06 0.71% 0.38%
31-Mar-2016 04-Aug-2015 30-Jun-2015 1 320,515 79,924 62,790 62,681 32,774 1,386,601 52.29% 19.59% 4.52% 819,359 39.12 9.48 7.65 1.85 4.00 0.97 1.6923 0.41   14.03%   9.80% 30-Jun-2015 8.51 21.75 111.24 5.03 0.90% 0.47% 04-Aug-2015 8.60 21.98 112.42 5.08 0.89% 0.47%
31-Mar-2015 05-May-2015 31-Mar-2015 4 305,110 67,331 55,008 54,969 11,655 777,015 21.20% 18.03% 7.07% 777,015 39.27 9.03 3.53 1.63 1.50 0.34 1.0000 0.23   11.01%   11.82% 31-Mar-2015 8.67 22.08 122.55 8.67 0.82% 0.17% 05-May-2015 8.22 20.93 116.19 8.22 0.86% 0.18%
31-Mar-2015 10-Feb-2015 31-Dec-2014 3 286,414 68,997 49,644 49,517 23,247 1,172,134 46.95% 17.33% 4.22% 774,913 36.96 8.48 6.39 1.47 3.00 0.69 1.5126 0.35   2.82%   -14.44% 31-Dec-2014 7.03 19.02 110.02 4.65 0.91% 0.43% 10-Feb-2015 7.55 20.43 118.15 4.99 0.85% 0.40%
31-Mar-2015 18-Nov-2014 30-Sep-2014 2 275,238 64,902 48,314 48,160 23,079 1,109,141 47.92% 17.55% 4.34% 769,329 35.78 8.14 6.26 1.43 3.00 0.68 1.4417 0.33   -15.64%   -23.89% 30-Sep-2014 7.08 19.79 113.10 4.91 0.88% 0.42% 18-Nov-2014 6.80 19.01 108.63 4.72 0.92% 0.44%
31-Mar-2015 05-Aug-2014 30-Jun-2014 1 279,198 75,651 57,241 57,087 30,244 1,014,409 52.98% 20.50% 5.63% 756,119 36.93 8.26 7.55 1.69 4.00 0.89 1.3416 0.30   16.13%   -9.26% 30-Jun-2014 6.21 16.82 82.25 4.63 1.22% 0.64% 05-Aug-2014 6.72 18.20 89.01 5.01 1.12% 0.60%
31-Mar-2014 06-May-2014 31-Mar-2014 4 280,373 70,272 49,395 49,157 25,950 942,361 52.79% 17.62% 5.22% 741,432 37.82 8.30 6.63 1.45 3.50 0.77 1.2710 0.28   -15.06%   -21.09% 31-Mar-2014 6.85 18.11 103.32 5.39 0.97% 0.51% 06-May-2014 6.02 15.92 90.80 4.74 1.10% 0.58%
31-Mar-2014 11-Feb-2014 31-Dec-2013 3 267,820 74,673 57,989 57,876 25,936 913,344 44.81% 21.65% 6.34% 741,049 36.14 7.92 7.81 1.71 3.50 0.77 1.2325 0.27   -8.53%   -4.38% 31-Dec-2013 7.23 20.01 92.57 5.87 1.08% 0.48% 11-Feb-2014 7.01 19.40 89.76 5.69 1.11% 0.50%
31-Mar-2014 12-Nov-2013 30-Sep-2013 2 280,953 82,300 63,326 63,273 25,901 872,575 40.94% 22.54% 7.25% 740,035 37.96 8.31 8.55 1.87 3.50 0.77 1.1791 0.26   0.57%   7.98% 30-Sep-2013 7.48 19.70 87.49 6.34 1.14% 0.47% 12-Nov-2013 7.55 19.89 88.30 6.40 1.13% 0.46%
31-Mar-2014 06-Aug-2013 30-Jun-2013 1 278,014 81,917 63,015 62,912 29,398 806,758 46.73% 22.67% 7.80% 734,953 37.83 8.23 8.56 1.86 4.00 0.87 1.0977 0.24   0.99%   17.91% 28-Jun-2013 6.40 16.92 74.77 5.83 1.34% 0.62% 06-Aug-2013 6.79 17.95 79.32 6.19 1.26% 0.59%
31-Mar-2013 07-May-2013 31-Mar-2013 4 269,772 81,318 62,422 62,293 25,589 765,355 41.08% 23.14% 8.14% 731,138 36.90 7.98 8.52 1.84 3.50 0.76 1.0468 0.23   2.91%   24.56% 29-Mar-2013 4.94 13.39 57.98 4.72 1.72% 0.71% 07-May-2013 5.45 14.77 63.97 5.21 1.56% 0.64%
31-Mar-2013 05-Feb-2013 31-Dec-2012 3 259,565 78,368 60,621 60,529 25,585 726,055 42.27% 23.35% 8.34% 731,026 35.51 7.68 8.28 1.79 3.50 0.76 0.9932 0.21   3.30%   19.38% 31-Dec-2012 4.75 13.38 57.37 4.78 1.74% 0.74% 05-Feb-2013 4.65 13.10 56.16 4.68 1.78% 0.75%
31-Mar-2013 06-Nov-2012 30-Sep-2012 2 255,019 76,282 58,575 58,597 25,604 689,630 43.70% 22.97% 8.50% 731,548 34.86 7.55 8.01 1.73 3.50 0.76 0.9427 0.20   9.82%   27.03% 28-Sep-2012 4.40 12.62 54.93 4.67 1.82% 0.80% 06-Nov-2012 4.89 14.03 61.05 5.19 1.64% 0.72%
31-Mar-2013 07-Aug-2012 30-Jun-2012 1 247,678 69,914 53,435 53,358 - 654,183 - % 21.57% 8.16% 730,931 33.89 7.33 7.30 1.58 0.00 0.00 0.8950 0.19   6.69%   -2.59% 29-Jun-2012 4.02 11.86 55.07 4.49 1.82% 0.00% 07-Aug-2012 4.50 13.28 61.64 5.03 1.62% 0.00%
31-Mar-2012 09-May-2012 31-Mar-2012 4 240,217 64,460 50,066 50,012 21,855 619,922 43.70% 20.84% 8.07% 364,253 65.95 7.11 13.73 1.48 6.00 0.65 1.7019 0.18   -1.36%   -4.55% 30-Mar-2012 6.62 10.04 48.22 3.89 2.07% 0.91% 09-May-2012 6.51 9.87 47.41 3.83 2.11% 0.92%
31-Mar-2012 22-Feb-2012 31-Dec-2011 3 241,951 63,902 50,663 50,703 21,839 587,179 43.07% 20.94% 8.64% 363,984 66.47 7.16 13.93 1.50 6.00 0.65 1.6132 0.17   9.92%   3.05% 30-Dec-2011 4.87 7.33 34.96 3.02 2.86% 1.23% 22-Feb-2012 6.64 9.99 47.67 4.12 2.10% 0.90%
31-Mar-2012 08-Nov-2011 30-Sep-2011 2 229,542 59,551 46,171 46,127 21,826 555,088 47.32% 20.11% 8.31% 363,777 63.10 6.79 12.68 1.36 6.00 0.65 1.5259 0.16   -15.79%   -2.06% 30-Sep-2011 4.58 7.26 36.12 3.00 2.77% 1.31% 08-Nov-2011 4.55 7.21 35.88 2.98 2.79% 1.32%
31-Mar-2012 09-Aug-2011 30-Jun-2011 1 219,371 70,670 54,746 54,774 - 529,045 - % 24.96% 10.35% 363,705 60.32 6.49 15.06 1.62 0.00 0.00 1.4546 0.16   4.53%   32.11% 30-Jun-2011 4.65 7.71 30.88 3.20 3.24% 0.00% 09-Aug-2011 4.49 7.44 29.81 3.09 3.35% 0.00%
31-Mar-2011 10-May-2011 31-Mar-2011 4 192,524 66,290 52,434 52,398 43,634 494,381 83.28% 27.24% 10.60% 363,622 52.95 5.70 14.41 1.55 12.00 1.29 1.3596 0.15   6.49%   12.90% 31-Mar-2011 4.54 8.57 31.51 3.34 3.17% 2.64% 10-May-2011 4.75 8.97 32.96 3.49 3.03% 2.53%
31-Mar-2011 07-Feb-2011 31-Dec-2010 3 188,123 62,206 49,211 49,203 18,169 457,907 36.93% 26.16% 10.75% 363,389 51.77 5.57 13.54 1.46 5.00 0.54 1.2601 0.14   4.47%   32.27% 30-Dec-2010 4.45 8.60 32.87 3.53 3.04% 1.12% 07-Feb-2011 4.69 9.06 34.64 3.72 2.89% 1.07%
31-Mar-2011 09-Nov-2010 30-Sep-2010 2 184,312 61,018 47,111 47,099 14,536 422,182 30.86% 25.56% 11.16% 363,418 50.72 5.45 12.96 1.39 4.00 0.43 1.1617 0.12   13.60%   42.27% 30-Sep-2010 3.92 7.73 30.25 3.37 3.31% 1.02% 09-Nov-2010 4.61 9.09 35.57 3.97 2.81% 0.87%
31-Mar-2011 10-Aug-2010 30-Jun-2010 1 169,958 53,764 41,450 41,461 - 386,815 - % 24.39% 10.72% 242,320 70.14 5.03 17.11 1.23 0.00 0.00 1.5963 0.11   -10.66%   57.20% 30-Jun-2010 6.69 9.54 39.10 4.19 2.56% 0.00% 10-Aug-2010 6.58 9.38 38.46 4.12 2.60% 0.00%
31-Mar-2010 11-May-2010 31-Mar-2010 4 163,385 56,562 46,455 46,409 24,234 354,307 52.22% 28.43% 13.10% 242,344 67.42 4.83 19.15 1.37 10.00 0.72 1.4620 0.10   24.76%   49.67% 31-Mar-2010 6.83 10.13 35.67 4.67 2.80% 1.46% 11-May-2010 6.54 9.70 34.15 4.47 2.93% 1.53%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.
  7 people like this.
 
yingkang87 Good quarter tomorrow Rm7
11/02/2020 6:02 PM
Fooksing Wong CONGRATS TO ALL :)
11/02/2020 6:20 PM
no buy no feel fuyoh if factor in Q1 corno virus result lagi bagus next quarter
11/02/2020 7:25 PM
itstime Anyone realise usually Harta every QR mentioned about they working on FDA approval. Suddenly this QR not mention anything about FDA...
11/02/2020 8:29 PM
stock_hunt got liao mai no need update lo...lol..wait to announce...hehe
11/02/2020 9:20 PM
gemfinder No surprise.. sell
11/02/2020 9:30 PM
kk7198 Just keep and not need to sell,just spend your quarterly dividend.
11/02/2020 9:51 PM
stanic88 As long as stays at rm6.00 until next quarter with 30% yoy improve, or 40% yoy growth consider good d.
12/02/2020 12:29 AM
Mabel Well done Malaysia.

18 millions contribution from the industry is very commendable..

Very proud to be associated with this company!

Happy to be on board together with her sister Top Gloves..

Meow..
12/02/2020 12:42 AM
mileskoon If you guys are looking for virus theme play, take a look at biohldg, it is one of the pharmacy and health supplement counter. The demand of vitamin and health supplement is increasing recently. Surprisingly, the share price is still trading at bottom, means the downside risk is limited, while upside risk is huge. It would rebound back it's fair value in near future. The beast is yet to wake up.
12/02/2020 7:09 AM
kk7198 @mileskoon, Harta is for long term as their management is cleaner...not like Topglove with Aspion saga and is far sighted like AMG which is getting approval from FDA in this year.Now is not virus theme play as the virus is peaking this month.
12/02/2020 7:25 AM
gemfinder New virus cases drop sgsin.. peak soon. Sell gloves
12/02/2020 7:28 AM
kk7198 Sell but make sure to collect back.
12/02/2020 8:13 AM
ov123 This is easily one of the best listed glove companies in Bursa.
12/02/2020 9:59 AM
learner35 1st timer buy share, should i buy some now or wait?
12/02/2020 10:34 AM
T1T4N Its not about the virus cases drop or what.
Whole world has HEALTH CONCIOUS UP LEVEL to MAXIMUM NOW.

Olympic 2020 is at JAPAN, the most affected country outside china.
Coming Euro2020 also (football)

Do you think the demand will DROP due to virus case turn better?

Think again.
12/02/2020 1:06 PM
Mabel Just buy and forget..
12/02/2020 2:13 PM
Chelsea Global glove demand surge where Malaysia order increase from 192B to 230B (additional 38B) which equivalent to half Top glove. This demand will continue grow due health concern awareness which arise from flu virus in US and COVID-19. As u can c, past 5 years the CAGR average is 12% compare with 7% on past decade. My target for Harta after include plant 6 is rm7 and plant 7 is rm7.8

CHELSEA
12/02/2020 2:17 PM
gggSTOCK TP 7 by end of the month
12/02/2020 3:14 PM
kenie New coronavirus vaccine may be faster to develop
KUALA LUMPUR (Feb 12): With the number of cases and deaths already surpassing that of SARS, teams around the world are racing to come up with a vaccine against the novel coronavirus (Covid-19).
At the time of writing, the virus has infected 45,194 people and killed 1,114 others.
Developing a vaccine safe for human use typically takes years, but there is reason to believe that the process will be speedier this time around, said academician and virologist Emeritus Prof Datuk Dr Lam Sai Kit.
“Advances in technology now makes it possible to come up with candidate vaccines in a matter of weeks, unlike traditional methods which can take years,” he told Bernama when contacted.
In addition to that, scientists in China sequenced the virus’s genome and made it available on Jan 10, just a month after the Dec 8 report of the first case of pneumonia from an unknown virus in Wuhan.
In contrast, scientists took more than half a year to sequence the SARS coronavirus after the outbreak began in late 2002.

How long will it take?
Lam noted that although candidate vaccines may be available in a matter of weeks, it would take much longer for them to be evaluated for human use.
“These candidate vaccines have to be tested in animal studies before human clinical trials can be started. It is still a long road ahead, and by the time a vaccine is ready, the outbreak may already be over — like in the case of SARS, where it took 20 months before a candidate vaccine was developed,” said Lam.
The vaccine never made it to the market because the virus was successfully contained with public health measures. The vaccine against MERS, meanwhile, is still being developed.
Immunologist Datuk Dr Musa Nordin said despite the pressure to come up with a vaccine as soon as possible, it must be noted that vaccine development remains an expensive and risky process.
“On average, it takes 10 years from pre-clinical trials through Phase 1-3 clinical trials before it is proven efficacious and safe for registration by regulatory bodies and use in man.
“However, the Covid-19 has the benefit of experience with previous candidate vaccines for MERS and SARS, allowing a jump start on the development of vaccines. If I had to hazard a best optimistic guess, I would say (a Covid-19 vaccine would be developed) within six months,” he said to Bernama.

What if it mutates?
One of the fears is that the Covid-19 would mutate after a vaccine is finally developed, affecting its efficacy.
However, it should be noted that Covid-19 does not undergo the same type of genome shuffling as the influenza virus, which is constantly mutating.
Like SARS, the genome of the Covid-19 comprises a single strand of RNA (ribonucleic acid). Microbes with such genome are known to mutate very quickly, but SARS has a molecular proofreading system that reduces its mutation rate.
Given the similarity to SARS at the genomic level, it has been suggested that the Covid-19 would not be as prone to mutation as the flu virus, which comprises multiple single-stranded RNA segments.
Therefore, if a vaccine is produced, it would still be effective.
Lam said that mutation is always a possibility with RNA viruses like the Covid-19.
“Usually, a major change happens when the virus jumps species. Hopefully, if there is a mutation, it will be a minor and not involving the spike protein, which is the important antigen used to produce the neutralising antibody in our immune system.
“With minor changes, the vaccine will still offer protection, or modify the severity of the disease,” he said.
CEPI
The Coalition of Endemic Preparedness Innovations (CEPI) in January announced that it would be funding three programmes to develop vaccines against the 2019-nCov.
It has engaged, among others, the Queensland University to work on a vaccine using its recently developed rapid response technology.
The university’s head of School of Chemistry and Molecular Biosciences Prof Paul Young said that they would be using the novel technology, known as the molecular clamp, for the rapid generation of the vaccine.
Young’s team of researchers have already experienced using this novel technology to produce candidate vaccines against influenza, Nipah, Ebola, and MERS. The team is optimistic that it will be able to develop the Covid-19 vaccine within six months.
“We are working around the clock to produce enough of the spike proteins in cells to produce this sub-unit vaccine,” said Young in an email.
A sub-unit vaccine is a fragment of a pathogen, typically a surface protein that is used to trigger an immune response. This in turn will stimulate acquired immunity against the pathogen from which it is derived.
CEPI is a non-profit organisation formed in 2017 to fund vaccine development for emerging infectious diseases. It is based in Oslo, Norway, and is a global partnership created to spearhead development
12/02/2020 3:34 PM
Alibaba Limskeong what happens to harta C28, mother up son go down, anyone know this.....?
12/02/2020 5:50 PM
James Ng https://klse.i3investor.com/blogs/general/2020-02-12-story-h1483791340.jsp
[转贴] [Facebook live video:浅谈Hartalega holdings bhd (Harta)] - James的股票投资James Share Investing
12/02/2020 9:28 PM
ching9 what happens to harta C28, mother up son go down, anyone know this.....? + 1
12/02/2020 5:50 PM

Same enquiry , Anyone possible reason to share?
12/02/2020 11:50 PM
gemfinder Virus peak liao. Sell gloves
13/02/2020 7:27 AM
James Ng https://klse.i3investor.com/blogs/general/2020-02-13-story-h1483791490.jsp
[转贴] [HARTALEGA HOLDINGS BHD:第六工厂的第一条生产线已于2020年1月投入使用,其余生产线将逐步投产,以满足不断增长的需求;一旦建成,第六工厂的年产量将达到47亿个] - James的股票投资James Share Investing
13/02/2020 7:53 AM
skybursa More than 14,000 new case & death over 280
13/02/2020 8:21 AM
skybursa 242 reported death
13/02/2020 8:24 AM
cheeseburger looking at spiking up confirmed case hit 60k, is very unlikely the demand for gloves not follow suit. It will only go up not come down. The stock analysis really need do homework before you call it too expensive. It is reasonable with much higher demand flooding the counter.
13/02/2020 9:04 AM
chl1989 it will go back to rm7 very soon
13/02/2020 12:21 PM
Jerichomy Pls dont accumulate now, my friend in adventa and ocncash told me that banker oredi left all the mask and glove counter...they are in steel counters...pls feel free to join them
13/02/2020 9:48 PM
JunJun left? it has barely begun
13/02/2020 9:56 PM
meistsk3134 rm7 next year
13/02/2020 10:30 PM
Chelsea lol Jerichomy don't listen to others. Please refer to the top 20 fund as closing 31 January 2020 where mostly new fund enter except Supermax.
14/02/2020 2:20 PM
gggSTOCK dont listen to those stupid analyst, they got paid even if they write rubbish
14/02/2020 5:06 PM
Rf888 Dont simply listen of analyst, please go do your own homework. Now china urgent need glove, next quarter result is very important. Please go study the result, you will get hint inside.

In line with growing rubber glove demand globally, Hartalega will continue with its NGC
capacity expansion plans. First line of Plant 6 was commissioned in January 2020 with
remaining production lines to come on stream progressively to cater for the rising demand.
Plant 6 will have an annual installed capacity of 4.7 billion pieces once completed. Plant 7 is
also in the expansion pipeline catering to small orders, focusing more on specialty products
and will have an annual installed capacity of 3.4 billion pieces. With the progressive
commissioning of Plant 6 and 7, Hartalega’s annual installed capacity is expected to increase
from the current 36.6 billion to 44.7 billion pieces by FY2022.
15/02/2020 1:50 PM
Rf888 The virus will effect many industries, only glove counter is super safe now and the fundamental is super good compare with others industry. This is the time, see back the H1N1 time how the glove counter result? Dont simply sell out your glove counter, is time to win big.
15/02/2020 1:53 PM
Rf888 When ppl scare, you need brave.
15/02/2020 1:54 PM
probability no of new confirmed infections per day had been clearly dropping....:

5th Feb: 3927
6th Feb: 3723
7th Feb: 3163
8th Feb: 3437
9th Feb: 2676
10th Feb: 3001
11th Feb: 2546
12th Feb: 1970
13th Feb: 1819
14th Feb: 1995
15th Feb: 1500

...........

90% of the above cases was in Hubei only, meaning only about 200 confirmed cases in China outside Hubei.

I think the war on the virus internationally is over.

what more today OUTSIDE China:

ONLY 1 CASE reported!
....................
15/02/2020 1:55 PM
Rf888 You can imagine how big 14 billion people china market?
15/02/2020 2:04 PM
probability may be can market in hubei only now...outside hubeis is only 200 confirmed cases per day...

even hubei will be completely under control in a month
15/02/2020 2:04 PM
Rf888 The real amount and you get the report amount at internet is big different, of course also hope this virus can get vaccine early.
15/02/2020 2:37 PM
gggSTOCK break 6.20 today then it will fly
17/02/2020 9:36 AM
hotmission fly down south...
19/02/2020 10:03 AM
chl1989 rm7 buy
19/02/2020 10:06 AM
sathishfiles 5.9 going down ??
19/02/2020 11:03 AM
yoyo Glove counters heat should b over concurrently with the dropping rate of virus infected cases. Harta TP RM5.20
19/02/2020 12:16 PM
WanUtama2015 Rf888, the China population is 1.4 billion ( 14亿 or 1400 million ), not 14 billion.
19/02/2020 3:32 PM
Gtrade yesterday new Covid-19 cases drop to 359. good sign but with 1400m China workforce and masses back to work, or released from quarantine, any sparks new clusters would swing the authority in panic mode again. This time it may even be too widespread to manage.For the next 6 monhs, heightened demand for gloves ,and hygien equipment will continue
20/02/2020 12:59 PM
ttluck no need worry la.....glove stock quite stable altough virus gone with the wind...hehe....looking longer term
20/02/2020 5:41 PM
presswood True, nx QR sure big green, epf will buy back after dividen, everywhere using glove, why worried
20/02/2020 7:49 PM